achieve sustained virologic

Related by string. * achieves . ACHIEVES . achieveing . ACHIEVE : TO ACHIEVE PROFITS OR . Achieves ISO #:# Certification [002] . Achieves VMware . Achieve ment / sustains . Sustaining . Sustained . sustaining : Maximum sustained winds . Maximum Sustained Winds . self sustaining / ViroLogic . Virologic : sustained virologic response . virologic response EVR . virologic suppression * *

Related by context. Frequent words. (Click for all words.) 67 peginterferon 67 disease modifying antirheumatic 65 pegylated interferon 65 HCV genotype 1 65 infliximab 64 plus ribavirin 64 nonresponders 64 fludarabine 63 sustained virologic response 62 FOLFIRI 62 dacarbazine 61 peg IFN 61 plus prednisone 61 peginterferon alfa 2b 61 Ph + ALL 61 Secondary endpoints include 61 peginterferon alfa 2a 61 neoadjuvant chemotherapy 61 tumor lysis syndrome 61 dasatinib 61 nilotinib 61 evaluable 60 virologic failure 60 sunitinib 60 DMARDs 60 DMARD 60 metastatic renal cell carcinoma 60 FOLFOX 60 Secondary endpoints included 60 interferon alfa 60 chronic HCV 60 rituximab 60 anti rheumatic 59 bortezomib 59 neoadjuvant 59 mg kg dose 59 nab paclitaxel 59 anti TNF 59 imatinib 59 chronic HCV infection 59 vandetanib 59 castration resistant prostate cancer 59 free survival PFS 59 abatacept 59 chemotherapy regimens 59 HCV infected 59 mg QD 59 relapsed refractory multiple myeloma 59 relapsed refractory 59 plus methotrexate 59 NNRTI 59 plus gemcitabine 59 TNF inhibitors 59 vinorelbine 58 gefitinib 58 antiviral therapy 58 LMWH 58 imatinib mesylate 58 decitabine 58 cytogenetic response 58 azathioprine 58 annualized relapse 58 hypercalcemia 58 undetectable viral load 58 administered subcutaneously 58 relapsed multiple myeloma 58 Amigal 58 Chronic Hepatitis C 58 autologous stem cell 58 Taxotere ® 58 reach statistical significance 57 adalimumab 57 refractory multiple myeloma 57 lamivudine 57 HRPC 57 drugs DMARDs 57 biologic therapy 57 fluorouracil 57 Lenalidomide 57 tocilizumab 57 ofatumumab 57 unresectable 57 REMICADE ® 57 lymphoma CTCL 57 hepatitis C HCV 57 adjuvant therapy 57 anakinra 57 NRTI 57 RECIST criteria 57 anthracycline 57 chronic angina 57 active comparator 57 monotherapy 57 EGFR mutations 56 adefovir 56 temsirolimus 56 severe renal impairment 56 Combination therapy 56 HER2 positive metastatic breast 56 PegIntron 56 NSCLC

Back to home page